Andrew Sharabi Lab


Dr. Sharabi’s research is focused on elucidating fundamental interactions between radiation and the immune system. He has published extensively on how radiation can augment immunotherapy and is currently the principal investigator on a novel randomized trial evaluating the benefit of SBRT in patients undergoing immunotherapy. He also serves as a Co-Investigator on a U-01 Moonshot Grant focused on immunotherapy in Head & Neck cancer.

ALT TEXT HERE

PEOPLE

PEOPLE


PUBLICATIONS

PUBLICATIONS

     
Publications

Lab News

Lab News

Lab News

DR. SHARABI’S LAB IS SUPPORTED IN PART BY A 4-YEAR $1.8M R-01 FROM THE NATIONAL INSTITUTES OF HEALTH

Featured Articles

ALT TEXT HERE

Radiation and Checkpoint Blockade Immunotherapy

The biological and mechanistic rationale for combining radiotherapy and checkpoint blockade immunotherapy is reviewed.

Read Now
ALT TEXT HERE

Radiation and Immunotherapy in Undifferentiated Pleomorphic Sarcoma

A case report of a bulky chemotherapy-refractory undifferentiated pleomorphic sarcoma of the maxillary sinus achieving a CR following radiation plus checkpoint blockade immunotherapy

Read Now
ALT TEXT HERE

T Cell Activation and Checkpoint Blockade Immunotherapy

A threshold model for immune activation to help understand clinical responses and immune therapy-related adverse events.

Read Now
Do Not Show